These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 35782620)

  • 1. Starting the conversation on gene therapy for phenylketonuria: Current perspectives of patients, caregivers, and advocates.
    Regier DS; Bąk A; Bausell H; O'Reilly E; Cowsert LM
    Mol Genet Metab Rep; 2022 Jun; 31():100855. PubMed ID: 35782620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unmet needs in PKU and the disease impact on the day-to-day lives in Brazil: Results from a survey with 228 patients and their caregivers.
    Martins AM; Pessoa ALS; Quesada AA; Ribeiro EM
    Mol Genet Metab Rep; 2020 Sep; 24():100624. PubMed ID: 32742934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unmet needs in phenylketonuria: an exploratory Italian survey among patients and caregivers.
    Rovelli V; Dicintio A; Cazzorla C
    Curr Med Res Opin; 2024 May; ():1-11. PubMed ID: 38646665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The personal burden for caregivers of children with phenylketonuria: A cross-sectional study investigating time burden and costs in the UK.
    MacDonald A; Smith TA; de Silva S; Alam V; van Loon JM
    Mol Genet Metab Rep; 2016 Dec; 9():1-5. PubMed ID: 27622144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of phenylketonuria in adult patients in Italy: a survey of six specialist metabolic centers.
    Burlina A; Leuzzi V; Spada M; Carbone MT; Paci S; Tummolo A
    Curr Med Res Opin; 2021 Mar; 37(3):411-421. PubMed ID: 33222540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response of patients with phenylketonuria in the US to tetrahydrobiopterin.
    Matalon R; Michals-Matalon K; Koch R; Grady J; Tyring S; Stevens RC
    Mol Genet Metab; 2005 Dec; 86 Suppl 1():S17-21. PubMed ID: 16143554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Tetrahydrobiopterin Therapy with Large Neutral Amino Acid Supplementation in Phenylketonuria: Effects on Potential Peripheral Biomarkers, Melatonin and Dopamine, for Brain Monoamine Neurotransmitters.
    Yano S; Moseley K; Fu X; Azen C
    PLoS One; 2016; 11(8):e0160892. PubMed ID: 27513937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A structural hypothesis for BH4 responsiveness in patients with mild forms of hyperphenylalaninaemia and phenylketonuria.
    Erlandsen H; Stevens RC
    J Inherit Metab Dis; 2001 Apr; 24(2):213-30. PubMed ID: 11405341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenylketonuria: a review of current and future treatments.
    Al Hafid N; Christodoulou J
    Transl Pediatr; 2015 Oct; 4(4):304-17. PubMed ID: 26835392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-year retrospective analysis of patients with phenylketonuria (PKU) and hyperphenylalaninemia treated at two specialized clinics.
    Levy H; Lamppu D; Anastosoaie V; Baker JL; DiBona K; Hawthorne S; Lindenberger J; Kinch D; Seymour A; McIlduff M; Watling S; Vockley J
    Mol Genet Metab; 2020 Mar; 129(3):177-185. PubMed ID: 31883647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A non-interventional observational study to identify and validate clinical outcome assessments for adults with phenylketonuria for use in clinical trials.
    Burton BK; Skalicky A; Baerwald C; Bilder DA; Harding CO; Ilan AB; Jurecki E; Longo N; Madden DT; Sivri HS; Wilcox G; Thomas J; Delaney K
    Mol Genet Metab Rep; 2021 Dec; 29():100810. PubMed ID: 34815941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of the US English version of the phenylketonuria - quality of life (PKU-QOL) questionnaire.
    Jurecki E; Cunningham A; Birardi V; Gagol G; Acquadro C
    Health Qual Life Outcomes; 2017 Mar; 15(1):46. PubMed ID: 28274259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of quality of life in PKU before and after introducing tetrahydrobiopterin (BH4); a prospective multi-center cohort study.
    Demirdas S; Maurice-Stam H; Boelen CC; Hofstede FC; Janssen MC; Langendonk JG; Mulder MF; Rubio-Gozalbo ME; van Spronsen FJ; de Vries M; Grootenhuis MA; Bosch AM
    Mol Genet Metab; 2013; 110 Suppl():S49-56. PubMed ID: 24100246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Phenylketonuria (PKU) in Iceland].
    Oddason KE; Eiriksdóttir L; Franzson L; Dagbjartsson A
    Laeknabladid; 2011 Jun; 97(6):349-52. PubMed ID: 21659675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging biosensors in Phenylketonuria.
    Shyam R; Sekhar Panda H; Mishra J; Jyoti Panda J; Kour A
    Clin Chim Acta; 2024 Jun; 559():119725. PubMed ID: 38734223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenylketonuria: translating research into novel therapies.
    Ho G; Christodoulou J
    Transl Pediatr; 2014 Apr; 3(2):49-62. PubMed ID: 26835324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of phenylalanine on cognitive, cerebral, and neurometabolic parameters in adult patients with phenylketonuria (the PICO study): a randomized, placebo-controlled, crossover, noninferiority trial.
    Trepp R; Muri R; Abgottspon S; Bosanska L; Hochuli M; Slotboom J; Rummel C; Kreis R; Everts R
    Trials; 2020 Feb; 21(1):178. PubMed ID: 32054509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The time consuming nature of phenylketonuria: a cross-sectional study investigating time burden and costs of phenylketonuria in the Netherlands.
    Eijgelshoven I; Demirdas S; Smith TA; van Loon JM; Latour S; Bosch AM
    Mol Genet Metab; 2013 Jul; 109(3):237-42. PubMed ID: 23731533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenylketonuria Scientific Review Conference: state of the science and future research needs.
    Camp KM; Parisi MA; Acosta PB; Berry GT; Bilder DA; Blau N; Bodamer OA; Brosco JP; Brown CS; Burlina AB; Burton BK; Chang CS; Coates PM; Cunningham AC; Dobrowolski SF; Ferguson JH; Franklin TD; Frazier DM; Grange DK; Greene CL; Groft SC; Harding CO; Howell RR; Huntington KL; Hyatt-Knorr HD; Jevaji IP; Levy HL; Lichter-Konecki U; Lindegren ML; Lloyd-Puryear MA; Matalon K; MacDonald A; McPheeters ML; Mitchell JJ; Mofidi S; Moseley KD; Mueller CM; Mulberg AE; Nerurkar LS; Ogata BN; Pariser AR; Prasad S; Pridjian G; Rasmussen SA; Reddy UM; Rohr FJ; Singh RH; Sirrs SM; Stremer SE; Tagle DA; Thompson SM; Urv TK; Utz JR; van Spronsen F; Vockley J; Waisbren SE; Weglicki LS; White DA; Whitley CB; Wilfond BS; Yannicelli S; Young JM
    Mol Genet Metab; 2014 Jun; 112(2):87-122. PubMed ID: 24667081
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.